199 related articles for article (PubMed ID: 30816167)
21. Comparison of urine, self-collected vaginal swab, and cervical swab samples for detecting human papillomavirus (HPV) with Roche Cobas HPV, Anyplex II HPV, and RealTime HR-S HPV assay.
Cho HW; Ouh YT; Hong JH; Min KJ; So KA; Kim TJ; Paik ES; Lee JW; Moon JH; Lee JK
J Virol Methods; 2019 Jul; 269():77-82. PubMed ID: 30998958
[TBL] [Abstract][Full Text] [Related]
22. Experience with high-risk human papillomavirus testing on vaginal brush-based self-samples of non-attendees of the cervical screening program.
Gök M; van Kemenade FJ; Heideman DA; Berkhof J; Rozendaal L; Spruyt JW; Beliën JA; Babovic M; Snijders PJ; Meijer CJ
Int J Cancer; 2012 Mar; 130(5):1128-35. PubMed ID: 21484793
[TBL] [Abstract][Full Text] [Related]
23. DNA methylation analysis in liquid-based cytology for cervical cancer screening.
Apostolidou S; Hadwin R; Burnell M; Jones A; Baff D; Pyndiah N; Mould T; Jacobs IJ; Beddows S; Kocjan G; Widschwendter M
Int J Cancer; 2009 Dec; 125(12):2995-3002. PubMed ID: 19609949
[TBL] [Abstract][Full Text] [Related]
24. Cross-sectional study of HPV testing in self-sampled urine and comparison with matched vaginal and cervical samples in women attending colposcopy for the management of abnormal cervical screening.
Sargent A; Fletcher S; Bray K; Kitchener HC; Crosbie EJ
BMJ Open; 2019 Apr; 9(4):e025388. PubMed ID: 31036707
[TBL] [Abstract][Full Text] [Related]
25. Performance and Diagnostic Accuracy of Human Papillomavirus Testing on Self-Collected Urine and Vaginal Samples in a Referral Population.
Cho HW; Hong JH; Min KJ; Ouh YT; Seong SJ; Moon JH; Cho SH; Lee JK
Cancer Res Treat; 2021 Jul; 53(3):829-836. PubMed ID: 33421987
[TBL] [Abstract][Full Text] [Related]
26. The use of host cell DNA methylation analysis in the detection and management of women with advanced cervical intraepithelial neoplasia: a review.
Kremer WW; Steenbergen R; Heideman D; Kenter GG; Meijer C
BJOG; 2021 Feb; 128(3):504-514. PubMed ID: 32619334
[TBL] [Abstract][Full Text] [Related]
27. DNA methylation testing for endometrial cancer detection in urine, cervicovaginal self-samples and cervical scrapes.
Wever BMM; van den Helder R; van Splunter AP; van Gent MDJM; Kasius JC; Trum JW; Verhoeve HR; van Baal WM; Hulbert A; Verhoef L; Heideman DAM; Lissenberg-Witte BI; van Trommel NE; Steenbergen RDM; Bleeker MCG
Int J Cancer; 2023 Jul; 153(2):341-351. PubMed ID: 36912267
[TBL] [Abstract][Full Text] [Related]
28. CyclinA1 Promoter Methylation in Self-Sampling Test.
Oranratanaphan S; Kengsakul M; Triratanachat S; Kitkumthorn N; Mutirangura A; Termrungruanglert W
Asian Pac J Cancer Prev; 2020 Oct; 21(10):2913-2917. PubMed ID: 33112548
[TBL] [Abstract][Full Text] [Related]
29. Clinical validation of hrHPV testing on vaginal and urine self-samples in primary cervical screening (cross-sectional results from the Papillomavirus Dumfries and Galloway-PaVDaG study).
Stanczuk G; Baxter G; Currie H; Lawrence J; Cuschieri K; Wilson A; Arbyn M
BMJ Open; 2016 Apr; 6(4):e010660. PubMed ID: 27113237
[TBL] [Abstract][Full Text] [Related]
30. Identification and Validation of a 3-Gene Methylation Classifier for HPV-Based Cervical Screening on Self-Samples.
Verlaat W; Snoek BC; Heideman DAM; Wilting SM; Snijders PJF; Novianti PW; van Splunter AP; Peeters CFW; van Trommel NE; Massuger LFAG; Bekkers RLM; Melchers WJG; van Kemenade FJ; Berkhof J; van de Wiel MA; Meijer CJLM; Steenbergen RDM
Clin Cancer Res; 2018 Jul; 24(14):3456-3464. PubMed ID: 29632006
[No Abstract] [Full Text] [Related]
31. First-void urine: A potential biomarker source for triage of high-risk human papillomavirus infected women.
Van Keer S; Pattyn J; Tjalma WAA; Van Ostade X; Ieven M; Van Damme P; Vorsters A
Eur J Obstet Gynecol Reprod Biol; 2017 Sep; 216():1-11. PubMed ID: 28689156
[TBL] [Abstract][Full Text] [Related]
32. BD-ProExC as adjunct molecular marker for improved detection of CIN2+ after HPV primary screening.
Depuydt CE; Makar AP; Ruymbeke MJ; Benoy IH; Vereecken AJ; Bogers JJ
Cancer Epidemiol Biomarkers Prev; 2011 Apr; 20(4):628-37. PubMed ID: 21297040
[TBL] [Abstract][Full Text] [Related]
33. Performance of a new HPV and biomarker assay in the management of hrHPV positive women: Subanalysis of the ongoing multicenter TRACE clinical trial (n > 6,000) to evaluate POU4F3 methylation as a potential biomarker of cervical precancer and cancer.
Kocsis A; Takács T; Jeney C; Schaff Z; Koiss R; Járay B; Sobel G; Pap K; Székely I; Ferenci T; Lai HC; Nyíri M; Benczik M
Int J Cancer; 2017 Mar; 140(5):1119-1133. PubMed ID: 27874187
[TBL] [Abstract][Full Text] [Related]
34. Cervical cancer risk in HPV-positive women after a negative FAM19A4/mir124-2 methylation test: A post hoc analysis in the POBASCAM trial with 14 year follow-up.
De Strooper LMA; Berkhof J; Steenbergen RDM; Lissenberg-Witte BI; Snijders PJF; Meijer CJLM; Heideman DAM
Int J Cancer; 2018 Sep; 143(6):1541-1548. PubMed ID: 29663363
[TBL] [Abstract][Full Text] [Related]
35. HPV Prevalence in the Dutch cervical cancer screening population (DuSC study): HPV testing using automated HC2, cobas and Aptima workflows.
Huijsmans CJ; Geurts-Giele WR; Leeijen C; Hazenberg HL; van Beek J; de Wild C; van der Linden JC; van den Brule AJ
BMC Cancer; 2016 Nov; 16(1):922. PubMed ID: 27894291
[TBL] [Abstract][Full Text] [Related]
36. Urine HPV-DNA detection for cervical cancer screening: prospects and prejudices.
Sehgal A; Gupta S; Parashari A; Sodhani P; Singh V
J Obstet Gynaecol; 2009 Oct; 29(7):583-9. PubMed ID: 19757259
[TBL] [Abstract][Full Text] [Related]
37. Selection of women at risk for cervical cancer in an HIV-infected South African population.
Van Zummeren M; Kremer WW; Van Aardt MC; Breytenbach E; Richter KL; Rozendaal L; Witte BI; De Strooper LMA; Hesselink AT; Heideman DAM; Snijders PJF; Steenbergen RDM; Dreyer G; Meijer CJLM
AIDS; 2017 Sep; 31(14):1945-1953. PubMed ID: 28692545
[TBL] [Abstract][Full Text] [Related]
38. Human papillomavirus DNA in urine samples of women with or without cervical cancer and their male partners compared with simultaneously collected cervical/penile smear or biopsy specimens.
Gupta A; Arora R; Gupta S; Prusty BK; Kailash U; Batra S; Das BC
J Clin Virol; 2006 Nov; 37(3):190-4. PubMed ID: 16931139
[TBL] [Abstract][Full Text] [Related]
39. Assessment of clinical performance of an ultrasensitive nanowire assay for detecting human papillomavirus DNA in urine.
Lee H; Choi M; Jo M; Park EY; Hwang SH; Cho Y
Gynecol Oncol; 2020 Mar; 156(3):641-646. PubMed ID: 31926639
[TBL] [Abstract][Full Text] [Related]
40. Methylation markers FAM19A4 and miR124-2 as triage strategy for primary human papillomavirus screen positive women: A large European multicenter study.
Bonde J; Floore A; Ejegod D; Vink FJ; Hesselink A; van de Ven PM; Valenčak AO; Pedersen H; Doorn S; Quint WG; Petry KU; Poljak M; Stanczuk G; Cuschieri K; de Sanjosé S; Bleeker M; Berkhof J; Meijer CJLM; Heideman DAM
Int J Cancer; 2021 Jan; 148(2):396-405. PubMed ID: 32997803
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
